Kate Dingwall

Kate Dingwall currently serves as Vice President of Clinical Development Operations and Vice President of Clinical Science and Operations at Adaptimmune, a position held since October 2020. Prior to this role, Kate Dingwall was with AstraZeneca from November 2017 to October 2020, where responsibilities included serving as Senior Director of Immuno-Oncology Program Management in Clinical Operations and Section Director of Oncology Program Management.